Meeting
2016 Gastrointestinal Cancers Symposium
Review of efficacy and safety of the new oral anticoagulants (NOACS) in the treatment of venous thromboembolism in gastrointestinal (GI) oncology patients.
Authors
Hitendra Patel
Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ
Hitendra Patel , Reem Diri , Ahmed Aljabri , Christopher Jon Campen , Emad Elquza , Steve Malangone , Ivo Abraham , Ali McBride
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 761)
DOI
10.1200/jco.2016.34.4_suppl.761
Abstract #
761
Poster Bd #
N14
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
An analysis of the efficacy and safety of direct oral anticoagulants (DOACs) in gastrointestinal cancer-associated venous thromboembolism (GI-CAVTE).
First Author: Alejandro Recio Boiles
Poster
2021 ASCO Quality Care Symposium
Evaluation of direct oral anticoagulant use for cancer-associated venous thromboembolism (VTE) in lung cancer.
First Author: Leila Rostamnjad
Poster
2022 ASCO Annual Meeting
Real-world utilization and comparative effectiveness of treatment options in cancer-associated thrombosis: A propensity score weighed analysis.
First Author: Irbaz Bin Riaz
Poster
2021 Genitourinary Cancers Symposium
A retrospective real-world major bleeding (MB) comparison of direct oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) in genitourinary cancer-associated venous thromboembolism (GU-CAVTE) with reported randomized clinical trials (RTC).
First Author: Ulyana Dashkevych